Paradigm Biocapital Advisors LP

Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Shares Owned: 4,216,084 shares
Security Ownership %: 9%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

14 Nov 2025 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,216,084 shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 9% ownership of the company. In their previous filing dated 12 Aug 2025, Paradigm Biocapital Advisors LP had reported owning 2,332,066 shares, indicating an increase of +81%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	9%	+80%	$84,110,876	4,216,084	+1,884,018	+81%	$19.95	13G/A	30 Sep 2025	14 Nov 2025, 16:31
Paradigm BioCapital Advisors LP	5%		$33,208,620	2,332,066			$14.24	13G	05 Aug 2025	12 Aug 2025, 16:30

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		2.8%	+0.16%	$104,772,836	4,473,648	+257,564	+6.1%	$23.42	Q4 2025
30 Sep 2025		2.5%	+2.5%	$84,110,876	4,216,084	+4,216,084	NEW	$19.95	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.